PCN82 Budget Impact Analysis of Subcutaneous Daratumumab for the Treatment of Patients with Multiple Myeloma in Sweden

Abstract

Authors

H. Toro-Diaz S. Li R. Morano M. Tambour V. Dansk A. Lam M. Slavcev

Full Text Cite This Article
Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×